Bayley Greenleaf

Cross-Border Challenge: Canada’s Cannabis Pioneers Face Threat from US Competitors

By Bayley Greenleaf / May 2, 2024 /

This week’s announcement that the Biden Administration will move ahead to reclassify cannabis to a much less restricted drug class and ease federal restrictions could be the ray of sunshine…

Read More

Congress Advances GOP-Led Psychedelics Bill for Veteran Mental Health

By Bayley Greenleaf / May 1, 2024 /

A congressional committee has approved a GOP-led psychedelics bill focused on military veterans’ access. The proposal, advanced by Rep. Derrick Van Orden (R-WI), aims to address the potential therapeutic benefits…

Read More

Opinion: Cannabis Rescheduling Marks a Milestone in Medical Acceptance

By Bayley Greenleaf / May 1, 2024 /

The Drug Enforcement Administration’s (DEA) recent decision to reschedule cannabis from Schedule I to Schedule III marks a significant turning point in U.S. drug policy. This move holds immense implications…

Read More

Branching Out: The Cannabis Industry Quest for New Heights

By Bayley Greenleaf / May 1, 2024 /

Implications of the Justice Department’s Recommendation on Cannabis Rescheduling For years, the dreams of the cannabis industry looked like they might go up in smoke, with the U.S. government classifying…

Read More

Telematics Solutions: Revolutionizing Logistics in the Cannabis Supply Chain

By Bayley Greenleaf / May 1, 2024 /

In an era where efficiency and compliance are paramount in the cannabis industry, the integration of telematics solutions has emerged as a game-changer in revolutionizing logistics within the supply chain.…

Read More

Federal Research Meeting to Examine Cannabis Efficacy for Pain Treatment

By Bayley Greenleaf / April 30, 2024 /

The National Institutes of Health (NIH) division, the National Center for Complementary and Integrative Health (NCCIH), is organizing an open meeting to discuss the potential use of cannabis components in…

Read More

Biden-Directed Health Agency Spurs Historic DEA Rescheduling of Cannabis

By Bayley Greenleaf / April 30, 2024 /

The Drug Enforcement Administration (DEA) has announced a groundbreaking move, concurring with the U.S. Department of Health and Human Services (HHS) recommendation to reclassify marijuana from Schedule I to Schedule…

Read More

High Stakes: Exploring the Political Impact of Weed Legalization for Biden and Trump

By Bayley Greenleaf / April 30, 2024 /

As the American electorate braces for another showdown between Joe Biden and Donald Trump, both candidates find themselves in a unique position to capitalize on an issue that resonates strongly…

Read More

From Seed to Contract: Vital Components of Risk Management for Cannabis Companies

By Bayley Greenleaf / April 29, 2024 /

To thrive in the cannabis sector, businesses must excel in smart contract management to ensure smooth operations and compliance. In this article, we’ll explore key areas of focus for effective…

Read More

High Stakes, High Risks: Understanding the Unique Challenges of the Cannabis Industry

By Bayley Greenleaf / April 29, 2024 /

The lucrative cannabis industry presents promising opportunities for entrepreneurs and investors alike. However, along with its potential for high returns comes a unique set of risks and challenges that businesses…

Read More